Navigation Links
New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
Date:6/10/2013

Minneapolis, MN (PRWEB) June 10, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the new Genedata Expressionist for Mass Spectrometry will be showcased at the 61st ASMS Conference on Mass Spectrometry. Compatible with data formats from all major MS vendors, Genedata Expressionist software significantly improves MS lab productivity. It provides an enterprise-level, integrated, and automated data analysis platform, which covers major biopharmaceutical applications including: characterization of post-translational modifications; glycosylation studies; mass analysis of intact proteins; and host cell protein analysis. During ASMS 2013, Genedata will preview the latest version of Genedata Expressionist at the Minneapolis Convention Center (June 10 – 13; Booth #46) and at the Rochester Hospitality Suite at the Hilton Minneapolis Hotel (June 10 – 12; 8pm – 11pm).

Data Processing Time Reduced from Weeks to Hours

Genedata Expressionist for Mass Spectrometry standardizes and automates the analysis of massive mass spectrometry datasets while offering state-of-the-art algorithms for high quality results. “We have implemented Genedata Expressionist for key parts of our workflow in biotherapeutics stability assessment and have successfully removed a major data analysis bottleneck,” noted a senior scientist at Janssen R&D. “What previously took us a month of work, we do now within a day. And Expressionist’s excellent data visualization tools help simplify our decision-making processes.”

“We are excited and encouraged by the market adoption of Genedata Expressionist for Mass Spectrometry, which effectively addresses a data analysis bottleneck for our customers,” said Dr. Othmar Pfannes, CEO of Genedata. “We are committed to advancing Genedata Expressionist as the vendor-agnostic platform of choice for MS data analysis and helping to make key processes in biopharmaceutical R&D as efficient as possible.”

About Genedata:

Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com.

Contacts
Allison Kurz
Genedata
Marketing & Communications
Phone: +41 61 511 8459
communications(at)genedata(dot)com

Jackie Thrasivoulos
Genedata
Public Relations
Phone: +1 508 881 3109
jackie.thrasivoulos(at)genedata(dot)com

Disclaimer:

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10794683.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener to Present at 10th Annual Ion Channel Retreat
2. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
3. Genedata Screener for HCS Advances Phenotypic Screening
4. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
5. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
6. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
10. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
11. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... for two-dimensional representations of a complex biological network, a depiction of a system ... big mess,” said Dmitry Korkin, PhD, associate professor of computer science at Worcester ...
(Date:10/12/2017)... ... 12, 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK ... module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants ... sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market will ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
Breaking Biology Technology:
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):